Skip to main content
Clinical Trials/NCT04590482
NCT04590482UnknownPhase 4

Use of Letrozole Pretreatment With Misoprostol for Induction of Abortion in First Trimester Missed Abortion

Shereen Rady Abou El-fetouh0 sites110 target enrollmentStarted: November 15, 2020Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Sponsor
Enrollment
110
Primary Endpoint
Complete abortion

Study Overview

Brief Summary

this study will compare the efficacy of using letrozole pre treatment before misoprostol versus using misoprostol only in the induction of first trimester missed abortion.

Detailed Description

Intervention type: drug

Intervention name: letrozole then misoprostol

Description :letrozole 2.5mg twice per day for 2days then misoprostol 800mcg for all patients to induce abortion

Arm group label:study group

Intervention type :drug

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Masking Description

participant- care provider -investigator- outcomes assessor

Eligibility Criteria

Ages
18 Years to 42 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Maternal age more than 18 years old.
  • Gestational age less than 13 weeks confirmed by ultrasound scan on day 1 of the study.
  • Hemoglobin >10 g/dl
  • Missed abortion

Exclusion Criteria

  • Mullerian Uterine anomalies as septate, bicornuate uterus.
  • Fibroid uterus.
  • Coagulopathy.
  • Medical disorder that contraindicate induction of abortion.
  • Allergy to misoprostol or letrozole.

Arms & Interventions

letrozole then misoprostol

Experimental

description:letrozole 2.5 mg each 12hours for 2 days at home followed by misoprostol 800mcg vaginally at hospital repeated after 4 hours if needed

Intervention: letrozole (Drug)

placebo then misoprostol

Placebo Comparator

Description:placebo each 12 hours for 2days at home followed by 800mcg misoprostol vaginally at hospital and repeat dose after 4 hours if needed

Intervention: placebo (Drug)

Outcomes

Primary Outcomes

Complete abortion

Time Frame: 6 hours

incidence of complete abortion without the need of surgical evacuation among 110patients in which 55 of patients took letrozole before misoprostol and the other 55 patients took placebo before misoprostol

Secondary Outcomes

  • surgical evacuation(6 hours)

Investigators

Sponsor
Shereen Rady Abou El-fetouh
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Shereen Rady Abou El-fetouh

principal investigator

Ain Shams University

Similar Trials